Amgen (AMGN) Assets Average (2009 - 2026)

Amgen has reported Assets Average for 17 years, with the latest figure at $94.1 billion in Q2 2026.

• On a quarterly basis, Assets Average rose 6.14% year-over-year to $94.1 billion in Q2 2026; TTM through Jun 2026 was $94.1 billion, a 6.14% increase from a year earlier, with the FY2025 full-year figure at $91.2 billion, down 3.48% from the prior year.
• Assets Average was $94.1 billion for Q2 2026 at Amgen, up from $91.5 billion in the prior quarter.
• The five-year high for Assets Average was $95.1 billion in Q1 2024, with the low at $59.2 billion in Q2 2022.
• Average Assets Average over 5 years is $83.9 billion, with a median of $90.4 billion recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Assets Average soared 51.06% in 2023, then decreased 4.7% in 2025.
• Over 5 years, Assets Average stood at $64.4 billion in 2022, then surged by 45.7% to $93.8 billion in 2023, then retreated by 2.65% to $91.4 billion in 2024, then slipped by 1.09% to $90.4 billion in 2025, then grew by 4.1% to $94.1 billion in 2026.
• The last three Assets Average figures came in at $94.1 billion (Q2 2026), $91.5 billion (Q1 2026), and $90.4 billion (Q4 2025), per Business Quant data.